Nanomedicine Market Forecasts to 2030 - Global Analysis By Product Type (Nano Molecules, Nanoshells, Nanotubes, Nanodevices, and Nanoparticles), Modality, Indication, Application and By Geography

4.6 (74 reviews)
4.6 (74 reviews)
Published: 2023 ID: SMRC24298

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2023)

US $235.9 MN

Projected Year Value (2030)

US $496.0 MN

CAGR (2023 - 2030)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific

According to Stratistics MRC, the Global Nanomedicine Market is accounted for $235.9 million in 2023 and is expected to reach $496.0 million by 2030 growing at a CAGR of 11.2% during the forecast period. A vast array of nanoscale materials, including nanoparticles, nanocarriers, and nanotubes, that are intended for particular medicinal uses are available on the market. Numerous medical applications, such as medication delivery, imaging, diagnostics, regenerative medicine, cancer therapy, and targeted therapy, have made use of nanomedicine. Particularly nanoparticles have demonstrated promise in delivering medications to precise parts of the body, lowering side effects, and enhancing therapeutic efficiency. 

According to a research article titled “Recent Advances in Nanomaterials Development for Nanomedicine and Cancer”, published in July 2021, a wide range of engineered nanomaterials and nanoplatforms with different shapes, sizes, and compositions has been developed for various biomedical applications.  

Market Dynamics: 


Growing interest on targeted drug delivery

With targeted medication delivery, medicinal compounds (such chemotherapy treatments) may be precisely delivered to certain disease locations, like cancer cells. By doing this, medications become more effective in treating patients while posing less of a risk to healthy tissues. Patients frequently benefit from this in terms of better treatment results and fewer side effects. Because the medication is concentrated at the intended place, targeted drug delivery can produce the intended therapeutic effect at lower drug dosages. This minimizes the expense of therapy as well as the chance of adverse consequences. Targeted medication delivery can improve patient compliance with therapy, which improves overall patient outcomes, by reducing side effects and improving treatment effectiveness.


Safety concerns

Patients may get less confident in nanomedicine products due to safety concerns, which may cause them to delay utilizing these treatments. Even if using nanomedicine therapies or taking part in clinical trials may have potential advantages, patients may be reluctant to do so. Because of safety concerns, healthcare providers including doctors and hospitals may be hesitant to propose or use nanomedicine therapy. As a result, these therapies may be adopted into clinical practice more slowly thus hampering the market growth.


Increasing advancements in nanotechnology

Novel nanomaterials with customized characteristics have been created as a result of on-going breakthroughs in nanotechnology. These materials are ideal for a range of medical applications because they may be engineered to have certain properties including size, shape, surface chemistry, and biocompatibility.  The creation of sophisticated medication delivery systems including liposomes, micelles, and nanoparticles has been made possible by nanotechnology. Moreover, the efficacy of therapies can be increased and adverse effects can be decreased by using these systems to encapsulate and release medications in a controlled and targeted way.


Stringent regulatory requirements

The release of goods utilizing nanomedicines into the market might be seriously delayed by onerous regulatory restrictions and protracted approval procedures. Access for patients to potentially life-saving or life-improving medicines may be hampered by delays. It may be especially difficult for small and newly established businesses in the field of nanomedicine to fulfil the legal and financial prerequisites for entering the market. These businesses may be disproportionately burdened by regulatory obstacles, which also restrict their capacity to compete. Because regulatory approval is unclear and takes time, companies and researchers may be deterred from investing in nanomedicine research. This may inhibit industry innovation.

Covid-19 Impact

The pandemic's urgency spurred study and development in the field of nanomedicine. The development of diagnostic testing, antiviral medication delivery systems, and vaccination platforms were significantly aided by nanotechnology. This prompt action showed how nanomedicine may be used to meet new health emergencies.  COVID-19 vaccines were developed and delivered using nanomedicine technology, including lipid nanoparticles. The messenger RNA (mRNA) utilized in various COVID-19 vaccines is encapsulated in these lipid nanoparticles, which guarantees their stability and effective uptake by cells.

The nanoshells segment is expected to be the largest during the forecast period

The nanoshells segment is estimated to have a lucrative growth, as these may be engineered to scatter and absorb light at particular wavelengths by adjusting the metallic shell's size and composition. This characteristic is utilized in a method known as ""photothermal therapy."" This approach involves the selective accumulation of nanoshells within cancer cells, which heat up in response to near-infrared light and inflict localized thermal damage on the cells. This method provides a less intrusive means of eliminating cancer cells. Moreover, nanoshells have been used to medical imaging. They can be used as contrast agents in imaging modalities such as optical coherence tomography and photoacoustic imaging which boosts the market.

The diagnostic imaging segment is expected to have the highest CAGR during the forecast period

The diagnostic imaging segment is anticipated to witness the highest CAGR growth during the forecast period, as in the field of nanomedicine, diagnostic imaging is essential because it offers non-invasive, incredibly detailed visual information on the interior structures and activities of the body. Diagnostic imaging has benefited from the application of nanotechnology, which has increased sensitivity, accuracy, and the capacity to target certain disease signs.  Advances in nanotechnology have been beneficial for molecular imaging techniques like single-photon emission computed tomography (SPECT) and positron emission tomography (PET).

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing an increase in the number of deadly illnesses, a spike in the market for nanomedicines, the availability of cutting-edge medical facilities staffed by qualified medical personnel, an increase in the number of R&D projects involving prominent figures, and an increase in government spending in the healthcare sector. Additionally, the nation is conducting a number of R&D projects on medications and diagnostics based on nanotechnology, which might propel market expansion. For example, in January 2020, scientists at Stanford University created a medication coated with nanoparticles that prevents mice from developing atherosclerosis by lowering the amount of plaque that accumulates in their arteries without having any negative side effects. 

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to public's growing interest in consensus conferences related to nanoscience and nanotechnology as well as the growing awareness of nanomedicine. For example, ChinaNANO 2022, the 9th International Conference on Nanoscience and Technology, was held in Beijing, China in August 2022. The purpose of the conference is to share scientific discoveries, advances in certain industries, technological innovations, and novel opportunities and challenges. Furthermore, the development of the R&D sector, the rise in healthcare reforms, the advancement of technology in the field of nanomedicines, and improvements in healthcare infrastructure are the main reasons why China and Japan are predicted to grow at a high compound annual growth rate (CAGR) in the Asia-Pacific market.

Key players in the market

Some of the key players profiled in the Nanomedicine Market include Abbott, Sanofi SA, Pfizer Inc., GE Healthcare, CombiMatrix Corporation, Johnson & Johnson Services Inc., Luminex Corporation, Merck & Company Inc., Nanosphere Inc. , Celgene Corporation, Bristol-Myers Squibb Company, DiaSo, Invitae Corporation, Mallinckrodt plc, Leadient BioSciences Inc., Teva Pharmaceuticals Ltd., Nanospectra Biosciences, Inc., Arrowhead Pharmaceuticals, Inc., Ablynx  and CytImmune Sciences 

Key Developments:

In November 2023, Abbott has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV infections to the Alinity m family of diagnostic assays.

In October 2023, Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment. Collaboration supports Sanofi’s immunology strategy of exploring novel mechanisms of action for chronic inflammatory diseases

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

Product Types Covered:
• Nano Molecules
• Nanoshells
• Nanotubes
• Nanodevices
• Nanoparticles

Indications Covered:
• Infectious Diseases 
• Cardiovascular Diseases 
• Oncological Diseases 
• Orthopedic Diseases 
• Neurological Disorders 
• Urological Disorders 
• Ophthalmological Diseases 
• Other Indications 
Applications Covered:
• Diagnostic Imaging
• Regenerative Medicine
• Drug Delivery
• Vaccines
• Implants
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary  
2 Preface   
 2.1 Abstract  
 2.2 Stake Holders 
 2.3 Research Scope 
 2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
 2.5 Research Sources 
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions
3 Market Trend Analysis 
 3.1 Introduction 
 3.2 Drivers  
 3.3 Restraints 
 3.4 Opportunities 
 3.5 Threats  
 3.6 Product Analysis 
 3.7 Application Analysis
 3.8 Emerging Markets 
 3.9 Impact of Covid-19 
4 Porters Five Force Analysis 
 4.1 Bargaining power of suppliers
 4.2 Bargaining power of buyers
 4.3 Threat of substitutes
 4.4 Threat of new entrants
 4.5 Competitive rivalry 
5 Global Nanomedicine Market, By Product Type
 5.1 Introduction 
 5.2 Nano Molecules 
 5.3 Nanoshells 
 5.4 Nanotubes 
 5.5 Nanodevices 
 5.6 Nanoparticles 
  5.6.1 Metal & Metal Oxide Nanoparticles
  5.6.2 Dendrimers
  5.6.3 Hydrogel Nanoparticles
  5.6.4 Inorganic nanoparticles
  5.6.5 Liposomes
  5.6.6 Polymer and Polymer Drug Conjugates
6 Global Nanomedicine Market, By Indication
 6.1 Introduction 
 6.2 Infectious Diseases 
 6.3 Cardiovascular Diseases
 6.4 Oncological Diseases
 6.5 Orthopedic Diseases
 6.6 Neurological Disorders
 6.7 Urological Disorders
 6.8 Ophthalmological Diseases
 6.9 Other Indications 
7 Global Nanomedicine Market, By Application
 7.1 Introduction 
 7.2 Diagnostic Imaging 
 7.3 Regenerative Medicine
 7.4 Drug Delivery 
 7.5 Vaccines  
 7.6 Implants  
 7.7 Other Applications 
8 Global Nanomedicine Market, By Geography
 8.1 Introduction 
 8.2 North America 
  8.2.1 US 
  8.2.2 Canada 
  8.2.3 Mexico 
 8.3 Europe  
  8.3.1 Germany 
  8.3.2 UK 
  8.3.3 Italy 
  8.3.4 France 
  8.3.5 Spain 
  8.3.6 Rest of Europe
 8.4 Asia Pacific 
  8.4.1 Japan 
  8.4.2 China 
  8.4.3 India 
  8.4.4 Australia 
  8.4.5 New Zealand
  8.4.6 South Korea
  8.4.7 Rest of Asia Pacific
 8.5 South America 
  8.5.1 Argentina
  8.5.2 Brazil 
  8.5.3 Chile 
  8.5.4 Rest of South America
 8.6 Middle East & Africa
  8.6.1 Saudi Arabia
  8.6.2 UAE 
  8.6.3 Qatar 
  8.6.4 South Africa
  8.6.5 Rest of Middle East & Africa
9 Key Developments  
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
 9.2 Acquisitions & Mergers
 9.3 New Product Launch
 9.4 Expansions 
 9.5 Other Key Strategies
10 Company Profiling  
 10.1 Abbott  
 10.2 Sanofi SA  
 10.3 Pfizer Inc. 
 10.4 GE Healthcare 
 10.5 CombiMatrix Corporation
 10.6 Johnson & Johnson Services Inc.
 10.7 Luminex Corporation
 10.8 Merck & Company Inc.
 10.9 Nanosphere Inc.   
 10.10 Celgene Corporation
 10.11 Bristol-Myers Squibb Company
 10.12 DiaSorin S.p.A. 
 10.13 Invitae Corporation 
 10.14 Mallinckrodt plc 
 10.15 Leadient BioSciences Inc.
 10.16 Teva Pharmaceuticals Ltd.
 10.17 Nanospectra Biosciences, Inc.
 10.18 Arrowhead Pharmaceuticals, Inc.
 10.19 Ablynx   
 10.20 CytImmune Sciences
List of Tables   
1 Global Nanomedicine Market Outlook, By Region (2021-2030) ($MN)
2 Global Nanomedicine Market Outlook, By Product Type (2021-2030) ($MN)
3 Global Nanomedicine Market Outlook, By Nano Molecules (2021-2030) ($MN)
4 Global Nanomedicine Market Outlook, By Nanoshells (2021-2030) ($MN)
5 Global Nanomedicine Market Outlook, By Nanotubes (2021-2030) ($MN)
6 Global Nanomedicine Market Outlook, By Nanodevices (2021-2030) ($MN)
7 Global Nanomedicine Market Outlook, By Nanoparticles (2021-2030) ($MN)
8 Global Nanomedicine Market Outlook, By Metal & Metal Oxide Nanoparticles (2021-2030) ($MN)
9 Global Nanomedicine Market Outlook, By Dendrimers (2021-2030) ($MN)
10 Global Nanomedicine Market Outlook, By Hydrogel Nanoparticles (2021-2030) ($MN)
11 Global Nanomedicine Market Outlook, By Inorganic nanoparticles (2021-2030) ($MN)
12 Global Nanomedicine Market Outlook, By Liposomes (2021-2030) ($MN)
13 Global Nanomedicine Market Outlook, By Polymer and Polymer Drug Conjugates (2021-2030) ($MN)
14 Global Nanomedicine Market Outlook, By Indication (2021-2030) ($MN)
15 Global Nanomedicine Market Outlook, By Infectious Diseases (2021-2030) ($MN)
16 Global Nanomedicine Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
17 Global Nanomedicine Market Outlook, By Oncological Diseases (2021-2030) ($MN)
18 Global Nanomedicine Market Outlook, By Orthopedic Diseases (2021-2030) ($MN)
19 Global Nanomedicine Market Outlook, By Neurological Disorders (2021-2030) ($MN)
20 Global Nanomedicine Market Outlook, By Urological Disorders (2021-2030) ($MN)
21 Global Nanomedicine Market Outlook, By Ophthalmological Diseases (2021-2030) ($MN)
22 Global Nanomedicine Market Outlook, By Other Indications (2021-2030) ($MN)
23 Global Nanomedicine Market Outlook, By Application (2021-2030) ($MN)
24 Global Nanomedicine Market Outlook, By Diagnostic Imaging (2021-2030) ($MN)
25 Global Nanomedicine Market Outlook, By Regenerative Medicine (2021-2030) ($MN)
26 Global Nanomedicine Market Outlook, By Drug Delivery (2021-2030) ($MN)
27 Global Nanomedicine Market Outlook, By Vaccines (2021-2030) ($MN)
28 Global Nanomedicine Market Outlook, By Implants (2021-2030) ($MN)
29 Global Nanomedicine Market Outlook, By Other Applications (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.